Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newtricious R&D is a Dutch life sciences company specializing in the development of clinically proven functional foods and nutraceuticals. The company focuses on bioactive ingredients derived from natural sources, such as egg-based peptides, to address chronic diseases and age-related conditions. Their lead product, MacuView, is a patented formulation designed to support eye health and slow the progression of Age-related Macular Degeneration (AMD). Newtricious bridges the gap between traditional nutrition and pharmaceuticals by conducting rigorous clinical trials to validate the efficacy of their products. The company collaborates extensively with academic institutions and global food and pharma partners to bring innovative health solutions to market. Their pipeline includes candidates for metabolic health and cardiovascular management, emphasizing a science-first approach to nutrition.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newtricious R&D.